(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 8.23% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.25%.
Stevanato Group Spa's revenue in 2024 is $1,164,898,924.On average, 3 Wall Street analysts forecast STVN's revenue for 2024 to be $364,851,858,483, with the lowest STVN revenue forecast at $355,853,846,547, and the highest STVN revenue forecast at $380,419,134,339. On average, 3 Wall Street analysts forecast STVN's revenue for 2025 to be $399,258,629,474, with the lowest STVN revenue forecast at $385,800,918,395, and the highest STVN revenue forecast at $422,767,066,098.
In 2026, STVN is forecast to generate $446,652,611,807 in revenue, with the lowest revenue forecast at $424,572,815,718 and the highest revenue forecast at $468,732,407,897.